Imaging & Diagnostics

Medical Cyclotron Market to Reach $405.4 Million by 2033
Imaging & Diagnostics Medical Cyclotron Market to Reach $405.4 Million by 2033

The global healthcare landscape is currently witnessing a transformative shift toward molecular medicine, where the ability to synthesize specific radioactive tracers at the point of care has become a fundamental requirement for modern oncology and neurology departments. As of 2026, the medical

AI Radiomics Models Improve Osteoporosis Screening on Spine CT
Imaging & Diagnostics AI Radiomics Models Improve Osteoporosis Screening on Spine CT

The silent progression of osteoporosis often remains undetected until a debilitating fracture occurs, creating a significant burden on global healthcare systems and reducing the quality of life for millions of aging individuals. Standard diagnostic procedures, while effective, are frequently

Global Cancer Biomarkers Market Analysis and Forecast to 2035
Imaging & Diagnostics Global Cancer Biomarkers Market Analysis and Forecast to 2035

The global healthcare landscape is currently undergoing a seismic shift from generalized treatment protocols toward a model of precision medicine, fundamentally altering how oncologists approach patient care. In the current landscape of 2026, the reliance on a "one-size-fits-all" strategy has

Can $32M Revitalize UI Health Care's Future?
Imaging & Diagnostics Can $32M Revitalize UI Health Care's Future?

Against a backdrop of nationwide financial headwinds and legislative uncertainty, the University of Iowa Health Care has unveiled a strategic, self-funded capital improvement plan exceeding $32 million, a proposal now awaiting approval from the Board of Regents. This comprehensive initiative is

Why Are So Many MG Patients Missing Key Tests?
Imaging & Diagnostics Why Are So Many MG Patients Missing Key Tests?

A startling revelation from a comprehensive analysis of U.S. insurance claims data indicates that the foundational diagnostic procedures for Myasthenia Gravis (MG) are being alarmingly overlooked, leaving a significant portion of patients without a definitive, lab-confirmed diagnosis. The study,

Telix Seeks EU Approval for New Brain Cancer Imaging Agent
Imaging & Diagnostics Telix Seeks EU Approval for New Brain Cancer Imaging Agent

Navigating the complexities of brain cancer treatment often involves a perilous journey through diagnostic uncertainty, where distinguishing between tumor regrowth and treatment-related side effects can be a formidable challenge for clinicians. In a significant move to address this critical need,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later